Keyphrases
Mandible
100%
Osteoporosis
100%
Osteoclast
100%
Osteoblast
100%
Bone Remodeling
100%
Wistar Rats
100%
Type 1 Diabetes Mellitus (T1DM)
100%
Treatment Group
66%
Runt-related Transcription Factor 2 (Runx2)
66%
Osteoprotegerin
66%
Osterix
66%
Tartrate-resistant Acid Phosphatase
66%
Remodeling Pathways
66%
Mandibular Bone
33%
Statistical Analysis
33%
No Significant Difference
33%
Female Wistar Rats
33%
Hematoxylin-eosin Staining
33%
Vascular Endothelial Growth Factor Expression
33%
Streptozotocin
33%
One-way Analysis of Variance
33%
Vascular Endothelial Growth Factor Receptor (VEGFR)
33%
Receptor Activator of nuclear factor-B Ligand
33%
Osteoporosis Model
33%
Molecular Expression
33%
Diabetes Mellitus Model
33%
Bilateral Ovariectomy
33%
Medicine and Dentistry
Lower Jaw
100%
Osteoporosis
100%
Osteoplasty
100%
Diabetes Mellitus
100%
Bone Remodeling
100%
Osteoclast
75%
Osteoblast
75%
Osteoclast Differentiation Factor
50%
Biological Marker
50%
Osteoprotegerin
50%
Acid Phosphatase Tartrate Resistant Isoenzyme
50%
Treatment Group
50%
Streptozocin
25%
Haematoxylin
25%
Eosin
25%
Vasculotropin
25%
Nuclear Factor
25%
Analysis of Variance
25%
Ovariectomy
25%
Transcription Factor RUNX2
25%
Alternative Complement Pathway C3 C5 Convertase
25%
Vasculotropin Receptor
25%
Biochemistry, Genetics and Molecular Biology
Osteoblast
100%
Bone Remodeling
100%
Osteoclast
100%
Wistar Rat
100%
RANKL
66%
RUNX2
66%
Osteoprotegerin
66%
Tartrate-Resistant Acid Phosphatase
66%
Periostin
33%
Vascular Endothelial Growth Factor
33%
Streptozotocin
33%
Complement Factor B
33%
Eosin
33%
VEGF Receptors
33%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetes Mellitus
100%
Wistar Rat
100%
Biological Marker
50%
Osteoclast Differentiation Factor
50%
Osteoprotegerin
50%
Acid Phosphatase Tartrate Resistant Isoenzyme
50%
Treatment Group
50%
Eosin
25%
Haematoxylin
25%
Vasculotropin
25%
Streptozotocin
25%
Nuclear Factor
25%
Alternative Complement Pathway C3 C5 Convertase
25%
Transcription Factor RUNX2
25%
Vasculotropin Receptor
25%